HIGHLIGHTS
- who: Shadab Md and collaborators from the Department of, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia have published the research: Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review, in the Journal: Pharmaceutics 2021, x of /2021/
- what: The present review describes the mechanism and up-to-date possible therapeutic approaches for lung cancer treatment and emphasizes future prospects to bring these novel approaches from bench to bedside. A Phase II clinical trial was conducted to determine the efficacy of pazopanib among patients with NSCLC. Unfortunately . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.